| Efficacy and cost of video-assisted thoracoscopic partial pleurectomy versus talc pleurodesis in patients with malignant pleural mesothelioma (MesoVATS): an open-label … RC Rintoul, AJ Ritchie, JG Edwards, DA Waller, AS Coonar, M Bennett, ... The Lancet 384 (9948), 1118-1127, 2014 | 245 | 2014 |
| Meta-analysis of randomised controlled trials of oral mandibular advancement devices and continuous positive airway pressure for obstructive sleep apnoea-hypopnoea LD Sharples, AL Clutterbuck-James, MJ Glover, MS Bennett, R Chadwick, ... Sleep medicine reviews 27, 108-124, 2016 | 234 | 2016 |
| A crossover randomised controlled trial of oral mandibular advancement devices for obstructive sleep apnoea-hypopnoea (TOMADO) TG Quinnell, M Bennett, J Jordan, AL Clutterbuck-James, MG Davies, ... Thorax 69 (10), 938-945, 2014 | 108 | 2014 |
| Clinical effectiveness and cost-effectiveness results from the randomised controlled Trial of Oral Mandibular Advancement Devices for Obstructive sleep apnoea-hypopnoea (TOMADO … L Sharples, M Glover, A Clutterbuck-James, M Bennett, J Jordan, ... Health Technology Assessment (Winchester, England) 18 (67), 1, 2014 | 67 | 2014 |
| Patient-reported outcomes assessed by the CAMPHOR questionnaire predict clinical deterioration in idiopathic pulmonary arterial hypertension and chronic thromboembolic … C McCabe, M Bennett, N Doughty, RMK Ross, L Sharples, J Pepke-Zaba Chest 144 (2), 522-530, 2013 | 67 | 2013 |
| A novel equivalence probability weighted power prior for using historical control data in an adaptive clinical trial design: A comparison to standard methods M Bennett, S White, N Best, A Mander Pharmaceutical statistics 20 (3), 462-484, 2021 | 16 | 2021 |
| Abstract GS3-02: GS3-02 Camizestrant, a next generation oral SERD vs fulvestrant in post-menopausal women with advanced ER-positive HER2-negative breast cancer: Results of the … M Oliveira, D Pominchuck, Z Nowecki, E Hamilton, Y Kulyaba, ... Cancer Research 83 (5_Supplement), GS3-02-GS3-02, 2023 | 14 | 2023 |
| Designs for adding a treatment arm to an ongoing clinical trial M Bennett, AP Mander Trials 21, 1-12, 2020 | 10 | 2020 |
| MesoVATS Collaborators. Efficacy and cost of video-assisted thoracoscopic partial pleurectomy versus talc pleurodesis in patients with malignant pleural mesothelioma (MesoVATS … RC Rintoul, AJ Ritchie, JG Edwards, DA Waller, AS Coonar, M Bennett, ... Lancet 384 (9948), 1118-1127, 2014 | 9 | 2014 |
| Mesovats: a multi-centre randomised controlled trial of video assisted thoracoscopic pleurectomy versus talc pleurodesis in malignant pleural mesothelioma RC Rintoul, AJ Ritchie, J Edwards, DA Waller, A Coonar, E Lovato, ... Journal of Thoracic Oncology 8, S2-S3, 2013 | 8 | 2013 |
| Clinical activity of camizestrant, a next-generation SERD, versus fulvestrant in patients with a detectable ESR1 mutation: Exploratory analysis of the SERENA-2 … M Oliveira, D Pominchuk, EP Hamilton, Y Kulyaba, T Melkadze, P Neven, ... Journal of Clinical Oncology 41 (16_suppl), 1066-1066, 2023 | 7 | 2023 |
| Improving the efficiency of clinical trial designs by using historical control data or adding a treatment arm to an ongoing trial MS Bennett | 6 | 2018 |
| Abstract OT-09-02: A randomized, open-label, parallel-group, multicenter phase 2 study comparing the efficacy and safety of oral AZD9833 versus fulvestrant in women with … M Oliveira, M Bennett, A Khalil, R Mather, R Maudsley, S McGuinness, ... Cancer Research 81 (4_Supplement), OT-09-02-OT-09-02, 2021 | 3 | 2021 |
| Randomised controlled trial of mandibular advancement devices for obstructive sleep apnoea (TOMADO): one year follow-up TG Quinnell, AL Clutterbuck-James, M Bennett, J Jordan, R Chadwick, ... Journal of Sleep Research 23, 116-116, 2014 | 2 | 2014 |
| The randomised, controlled, crossover Trial of Oral Mandibular Advancement Devices for Obstructive sleep apnoea–hypopnoea L Sharples, M Glover, A Clutterbuck-James, M Bennett, J Jordan, ... Clinical effectiveness and cost-effectiveness results from the randomised …, 2014 | 1 | 2014 |
| A randomized, open-label, parallel-group, multicenter phase 2 study comparing the efficacy and safety of oral AZD9833 versus fulvestrant in women with advanced ER-positive HER2 … M Oliveira, M Bennett, A Khalil, R Mather, R Maudsley, S McGuinness, ... CANCER RESEARCH 81 (4), 2021 | | 2021 |
| Progenitor cell-derived basophil activation test (PCBAT) predicts clinical reactivity to cat better than skin prick test M Bennett, J Wu, C Murray, G Gauvreau, R Cusack, S Bulfone-Paus, ... ALLERGY 75, 380-380, 2020 | | 2020 |
| S129 Progenitor cell-derived basophil activation test (PCBAT) predicts clinical reactivity in cat allergic asthmatics-a proof of concept study M Bennett, J Wu, CS Murray, G Gauvreau, R Cusack, S Bulfone-Paus, ... Thorax 74 (Suppl 2), A82-A83, 2019 | | 2019 |
| Incorporating historical control data into the design and analysis of clinical trials M Bennett, W Powley, J Wetherington, A Mander Trials 16, 1-1, 2015 | | 2015 |
| Adding a treatment arm to an ongoing clinical trial-utilizing historical data M Bennett | | 2015 |
